Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Solriamfetol (R228060) in Major Depressive Disorder
NCT00073203Phase 2Completed
- Sponsor
- Johnson & Johnson
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solriamfetol in major depressive disorder (MDD), sponsored by Johnson & Johnson. Status: completed.
02
Drugs
solriamfetol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00073203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073203.